Impact of maternal substance use during pregnancy on childhood outcome

Substance Abuse Mental Health Services Administration. Office of Applied Studies. National household survey on drug abuse 2002, 2003 and 2004. 2004. Behnke, 2001, The search for congenital malformations in newborns with fetal cocaine exposure, Pediatrics, 107, 10.1542/peds.107.5.e74 Frank, 1999, Level of in-utero cocaine exposure and neonatal ultrasound findings, Pediatrics, 104, 1101, 10.1542/peds.104.5.1101 Richardson, 1999, Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and no prenatal care sample, Pediatrics, 104, e18, 10.1542/peds.104.2.e18 Eyler, 1998, Birth outcome from a prospective, matched study of prenatal crack/cocaine use: 1. Interactive and dose effects on health and growth, Pediatrics, 101, 229, 10.1542/peds.101.2.229 Bateman, 2000, Dose-response effects of cocaine on newborn head circumference, Pediatrics, 106, e33, 10.1542/peds.106.3.e33 Lester, 1996, Human studies of cocaine exposed infants, vol. 164, 175 Lester, 1997, Data base of studies on prenatal cocaine exposure and child outcome, J Drug Issues, 27, 487, 10.1177/002204269702700304 Lester, 2001, The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report, Pediatrics, 107, 309, 10.1542/peds.107.2.309 Bauer, 2002, The Maternal Lifestyle Study (MLS): drug exposure during pregnancy and short-term maternal outcomes, Am J Obstet Gynecol, 186, 487, 10.1067/mob.2002.121073 Bauer, 2005, Acute neonatal effects of cocaine exposure during pregnancy, Arch Pediatr Adolesc Med, 159, 824, 10.1001/archpedi.159.9.824 Bada, 2002, Central and autonomic nervous systems (CNS/ANS) signs associated with in-utero cocaine/opiate exposure, Arch Dis Child Neonatal Ed, 87, F106, 10.1136/fn.87.2.F106 Bada, 2002, Gestational cocaine exposure and intrauterine growth (Maternal Lifestyle Study), Obstet Gynecol, 100, 916, 10.1016/S0029-7844(02)02199-3 Shankaran, 2004, Association between patterns of maternal substance use and infant birth weight, length and head circumference, Pediatrics, 114, e226, 10.1542/peds.114.2.e226 Bada, 2005, Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure, J Perinatol, 25, 631, 10.1038/sj.jp.7211378 Shankaran, 2002, Cocaine exposure (EXP) and small for gestational age status (SGA) at birth: effects on growth at 6-years, The Maternal Lifestyle Study. Pediatr Res, 51, 326A Needleman, 1998, Blood pressure in children exposed prenatally to cocaine, Clin Pediatr, 37, 659, 10.1177/000992289803701103 Horn, 1992, Persistent hypertension after prenatal cocaine exposure, J Pediatr, 121, 288, 10.1016/S0022-3476(05)81206-5 Shankaran, 2006, Fetal origin of childhood disease: intrauterine growth restriction in term infants and risk for hypertension at 6 years, Arch Pediatr Adolesc Med, 160, 977, 10.1001/archpedi.160.9.977 Joyce, 1995, The impact of prenatal exposure to cocaine on newborn costs and length of stay, Health Serv Res, 30, 341 Behnke, 1997, How fetal cocaine exposure increases neonatal hospital costs, Pediatrics, 99, 204, 10.1542/peds.99.2.204 Shankaran, 2003, Health-care utilization among mothers and infants following cocaine exposure, J Perinatol, 23, 361, 10.1038/sj.jp.7210946 Miller, 2005, Predictors of motor development in children prenatally exposed to cocaine, Neurotoxicology, 27, 213, 10.1016/j.ntt.2004.10.007 Hertzig, 1981, Neurological ‘soft’ signs in low-birthweight children, Dev Med Child Neurol, 23, 778, 10.1111/j.1469-8749.1981.tb02066.x Pine, 1996, Psychometrics of neurological soft signs, J Am Acad Child Adolesc Psychiatry, 35, 509, 10.1097/00004583-199604000-00017 Pine, 1997, Neurological soft signs: one-year stability and relationship to psychiatric symptoms in boys, J Am Acad Child Adolesc Psychiatry, 36, 1579 Breslau, 2000, Neurologic soft signs and low birthweight: their association and neuropsychiatric implications, Biol Psychiatry, 47, 71, 10.1016/S0006-3223(99)00131-6 Shankaran, 2004, Neurological correlates at 7years of age of intrauterine exposure to cocaine and alcohol, Pediatr Res, 55, 492A Lester, 2002, The Maternal Lifestyle Study (MLS): effects of substance exposure during pregnancy on neurodevelopmental outcome in one-month old infants, Pediatrics, 110, 1182, 10.1542/peds.110.6.1182 Lester, 2003, The Maternal Lifestyle Study (MLS): effects of substance and/or opiate exposure during pregnancy on auditory brain response at one month, J Pediatr, 142, 279, 10.1067/mpd.2003.112 Messinger, 2004, The Maternal Lifestyle Study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age, Pediatrics, 113, 1677, 10.1542/peds.113.6.1677 Bada H, Das A, Bauer CR, Shankaran S, Lester B, LaGasse L, et al. Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics (in press). Lester, 2005, Neurobiological dysregulation model of prenatal cocaine exposure and behavior problems at age 7, Pediatr Acad Soc (proceeds of meeting), 57, 1625 Seifer, 2004, Attachment status in children prenatally exposed to cocaine and other substances, Child Dev, 75, 850, 10.1111/j.1467-8624.2004.00710.x Lester, 2003, Prenatal cocaine exposure and 7-year outcome: IQ and special education, Pediatr Res, 53, 534A Wilson, 1973, Early development of infants of heroin-addicted mothers, Am J Dis Child, 126, 457 Zelson, 1971, Neonatal narcotic addiction: 10 year observation, Pediatrics, 48, 178, 10.1542/peds.48.2.178 Ostrea, 1976, A study of factors that influence the severity of neonatal narcotic withdrawal, J Pediatr, 88, 642, 10.1016/S0022-3476(76)80027-3 Bauer CR. Long term outcome following prenatal opiate exposure. Pediatr Acad Soc (personal communication). Harrell, 2001 Das, 2004, A repeated measures approach for simultaneous modeling of multiple neurobehavioral outcomes in newborns exposed to cocaine in utero, Am J Epidemiol, 159, 891, 10.1093/aje/kwh114 Raghunathan, 2001, A multivariate technique for multiply imputing missing values using a sequence of regression models, Surv Methodol, 27, 85